Diabetes is a metabolic illness in which an affected person’s blood has high glucose levels because of a lack of insulin production by the pancreas or in other words, resistant of body cells to insulins. Depending on the severity, diabetes has been divided in three form like type 1 diabetes, type 2 diabetes, and gestation diabetes.Diabetes is usually detected post 45 years of age. In type 1 diabetes the body is unable to release the appropriate amount of insulin; it’s the early onset of diabetes and also to an extent the insulin-dependent one. Approximately, 10% of all diabetes cases in the world is type 1. Anti-diabetic drugs like insulin are typically given to type 1 diabetes people with the help of a diabetes injection pens. The precise amount of insulin is administered with the help of this pen. Diabetes injection pens are way better than the conventional syringe insulin as they have made the procedure less painful and non-invasive. It helps diabetic people who are visually impaired and old. Innovation and enhancement in insulin injection has resulted in disposable and reusable insulin pen injectors. Presently, diabetes injection pens are a superior choice owing to their portability and travel- and user-friendliness.
Top Manufactures Analysis of Diabetes Injection Pen: Lantus Solostar Pen, NovoLog Flex Pen, Byetta Pen, Humalog KwikPen, Humulin Pen
To Browse Complete Report, Click Here: http://www.qyresearchgroups.com/report/global-diabetes-injection-pen-market-research-report-2016
The global diabetes injection pens market is anticipated to garner lucrative revenue share while growing at a higher CAGR during the forecast period owing to various other factors such as escalated occurrence of diabetes on a global level. According to WHO, in the year 2000 the total number of diabetes cases was 171 million which is probably approximated to reach 366 million by 2030. Furthermore, increased prevalence of juvenile onset type 1 diabetes below the age of 15 in alarmingly rising across many countries in the world. International Diabetes Federation (IDF) recorded that in a year; nearly 76,000 children below the age of 15 acquire type 1 diabetes. Owing to the user-convenience nature of the injection pens, the dependency on a skilled person for injection reduces and thereby promoting this industry’s market lucratively. Technological enhancement in the latest devices, getting more cost-efficient because of the increased competition, and budding global awareness, together further boosts the diabetes injection pens market on a global level.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/159298
Nevertheless, injection pens are more expensive than the conventional syringes and wastage of one or two unit of the insulin drug at the time of every injection, and shortage of availability are a few hindrances in the market growth. The market opportunities in the emerging countries are increasing with more number of market players investing to better the technology. Some of the prime market players of this industry on a global level are Lantus Solostar Pen, NovoLog Flex Pen, Byetta Pen, Humalog KwikPen, Humulin Pen, NovoPen3 Pen, NovoLog Mix Pen, SymlinPen, NovoPen3 PenMate, OptiClik Pen, Apidra SoloStar, Victoza, and Levemir.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China